147 related articles for article (PubMed ID: 31520927)
41. Corrigendum to "Discovery of novel BCR-ABL PROTACs based on the cereblon E3 ligase design, synthesis, and biological evaluation" [Eur. J. Med. Chem. 223 (2021) 11-05 113645].
Liu H; Ding X; Liu L; Mi Q; Zhao Q; Shao Y; Ren C; Chen J; Kong Y; Qiu X; Elvassore N; Yang X; Yin Q; Jiang B
Eur J Med Chem; 2023 Apr; 252():115295. PubMed ID: 36989810
[No Abstract] [Full Text] [Related]
42. Corrigendum to "Design, synthesis, and biological evaluation of 1,6-naphthyridine-2-one derivatives as novel FGFR4 inhibitors for the treatment of colorectal cancer" [Eur. J. Med. Chem. 259 (2023) 115703/5].
Fang B; Lai Y; Yan H; Ma Y; Ni Z; Zhu Q; Zhang J; Ye Y; Wang M; Wang P; Wang Y; Zhang S; Hui M; Wang D; Zhao Y; Li X; Wang K; Liu Z
Eur J Med Chem; 2024 Mar; 268():116230. PubMed ID: 38368135
[No Abstract] [Full Text] [Related]
43. Corrigendum to "Synthesis of the pH-sensitive nanoparticles based on the acylhydrazone bonds conjugated doxorubicin and studies on their in vivo anti-tumor effects" [Eur. J. Med. Chem. 260 (2023) 115715].
Shi Y; Pan X; Xu S; Zhu H; Zhao B; Sun Z; Dong R; Li N; Hou X; Yang X
Eur J Med Chem; 2023 Dec; 262():115887. PubMed ID: 37867086
[No Abstract] [Full Text] [Related]
44. Corrigendum to "Design, synthesis and biological evaluation of carbamate derivatives incorporating multifunctional carrier scaffolds as pseudo-irreversible cholinesterase inhibitors for the treatment of Alzheimer's disease" [Eur. J. Med. Chem. 265 (2024) 116071].
Liu Y; Ma C; Li Y; Li M; Cui T; Zhao X; Li Z; Jia H; Wang H; Xiu X; Hu D; Zhang R; Wang N; Liu P; Yang H; Cheng M
Eur J Med Chem; 2024 Mar; 267():116169. PubMed ID: 38290915
[No Abstract] [Full Text] [Related]
45. Corrigendum to "The role of sodium intake in nephrolithiasis: Epidemiology, pathogenesis, and future directions" [Eur J Intern Med 35 (2016) 16-19].
Afsar B; Kiremit MC; Sag AA; Tarim K; Acar O; Esen T; Solak Y; Covic A; Kanbay M
Eur J Intern Med; 2017 Jan; 37():90. PubMed ID: 27899242
[No Abstract] [Full Text] [Related]
46. Retraction notice to “Synthesis and biological screening of some novel amidocarbamate derivatives of ketoprofen” [Eur. J. Med. Chem. (2010) 3162-3168].
Eur J Med Chem; 2012 Jan; 47(1):626. PubMed ID: 22355807
[No Abstract] [Full Text] [Related]
47. Corrigendum to "Synthesis and SAR of novel capsazepine analogs with significant anti-cancer effects in multiple cancer types" [Bioorg. Med. Chem. 27 (1) (2019) 208-215].
De La Chapa J; Valdez M; Ruiz F; Gonzales K; Mitchell W; McHardy SF; Hart MJ; Polusani SR; Gonzales CB
Bioorg Med Chem; 2019 Jun; 27(11):2280. PubMed ID: 31014563
[No Abstract] [Full Text] [Related]
48. Corrigendum to "Metal-assisted synthesis of unsymmetrical magnolol and honokiol analogs and their biological assessment as GABA
Rycek L; Puthenkalam R; Schnürch M; Ernst M; Mihovilovic MD
Bioorg Med Chem Lett; 2015 Apr; 25(8):1811. PubMed ID: 28718421
[No Abstract] [Full Text] [Related]
49. Retraction notice to "Identification of novel aminothiazole and aminothiadiazole conjugated cyanopyridines as selective CHK1 inhibitors" [Eur. J. Med. Chem. 92 (2015) 459-470].
Gomha SM; Abdulla MM; Abou-Seri SM
Eur J Med Chem; 2016 Oct; 121():939. PubMed ID: 27523643
[No Abstract] [Full Text] [Related]
50. Corrigendum to "ATP7B variant spectrum in a French pediatric Wilson disease cohort" [Eur. J. Med. Genet. 64(10) (2021) 104305].
Couchonnal E; Bouchard S; Sandahl TD; Pagan C; Lion-François L; Guillaud O; Habes D; Debray D; Lamireau T; Broué P; Fabre A; Vanlemmens C; Sobesky R; Gottrand F; Bridoux-Henno L; Belmalih A; Poujois A; Brunet AS; Lachaux A; Bost M
Eur J Med Genet; 2021 Nov; 64(11):104341. PubMed ID: 34544667
[No Abstract] [Full Text] [Related]
51. Erratum to "Synthesis of functionalized new conjugates of batracylin with tuftsin/retro-tuftsin derivatives and their biological evaluation" [Eur. J. Med. Chem. 106 (2015) 85-94].
Januchta W; Serocki M; Dzierzbicka K; Cholewiński G; Skladanowski A
Eur J Med Chem; 2016 Jun; 116():318-319. PubMed ID: 27177783
[No Abstract] [Full Text] [Related]
52. Retraction notice to “Proton-pumping-ATPase-targeted antifungal activity of cinnamaldehyde based sulfonyl tetrazoles” [Eur. J. Med. Chem. 48 (2012) 363-370].
Eur J Med Chem; 2012 Nov; 57():483. PubMed ID: 22640886
[No Abstract] [Full Text] [Related]
53. Corrigendum to: Antipsychotics and severe hyponatremia: A Swedish population-based case-control study. Eur J Intern Med. 2019 Feb;60:71-77.
Falhammar H; Lindh JD; Calissendorff J; Skov J; Nathanson D; Mannheimer B
Eur J Intern Med; 2021 Oct; 92():142-143. PubMed ID: 34175184
[No Abstract] [Full Text] [Related]
54. Corrigendum to "ATP7B variant spectrum in a French pediatric Wilson disease cohort" [Eur. J. Med. Genet. 64 (10) (October 2021) 104305].
Couchonnal E; Bouchard S; Sandahl TD; Pagan C; Lion-François L; Guillaud O; Habes D; Debray D; Lamireau T; Broué P; Fabre A; Vanlemmens C; Sobesky R; Gottrand F; Bridoux-Henno L; Belmalih A; Poujois A; Collet C; Francou B; Brunet AS; Lachaux A; Misrahi M; Bost M
Eur J Med Genet; 2022 Mar; 65(3):104453. PubMed ID: 35183456
[No Abstract] [Full Text] [Related]
55. Corrigendum to: Associations of proton pump inhibitors and hospitalization due to hyponatremia: A population-based case-control study. Eur J Intern Med. 2019 Jan;59:65-69.
Falhammar H; Lindh JD; Calissendorff J; Skov J; Nathanson D; Mannheimer B
Eur J Intern Med; 2021 Sep; 91():107-108. PubMed ID: 34175185
[No Abstract] [Full Text] [Related]
56. Corrigendum to: Tramadol- and codeine-induced severe hyponatremia: A Swedish population-based case-control study. Eur J Intern Med. 2019 Nov;69:20-24.
Falhammar H; Calissendorff J; Skov J; Nathanson D; Lindh JD; Mannheimer B
Eur J Intern Med; 2021 Oct; 92():140-141. PubMed ID: 34172352
[No Abstract] [Full Text] [Related]
57. Corrigendum to "Discovery of 4-aminopyrimidine analogs as highly potent dual P70S6K/Akt inhibitors" [Bioorgan. Med. Chem. Lett. 50 (2021) 128352].
Xiao Y; Huck BR; Lan R; DeSelm L; Chen X; Qiu H; Neagu C; Johnson T; Mochalkin I; Gardberg A; Jiang X; Tian H; Dutt V; Santos D; Head J; Jackson J; Syed S; Lin J; Wilker E; Ma J; Clark A; Machl A; Bankston D; Jones CCV; Goutopoulos A; Sherer B
Bioorg Med Chem Lett; 2022 Jul; 67():128758. PubMed ID: 35484006
[No Abstract] [Full Text] [Related]
58. Corrigendum to 'Novel carbocyclic nucleoside analogs suppress glomerular mesangial cells proliferation and matrix protein accumulation through ROS-dependent mechanism in the diabetic milieu. II. Acylhydrazone-functionalized pyrimidines' [Bioorg. Med. Chem. Lett. 26 (2016) 1020-1024].
Bouhadir KH; Koubeissi A; Mohsen FA; Diab El-Harakeh M; Cheaib R; Younes J; Azzi G; Eid AA
Bioorg Med Chem Lett; 2019 Aug; 29(16):2439. PubMed ID: 31262558
[No Abstract] [Full Text] [Related]
59. Corrigendum to "Protein ligand-tethered synthetic calcium indicator for localization control and spatiotemporal calcium imaging in plant cells" [Bioorg. Med. Chem. Lett. 26 (2016) 9-14].
Takaoka Y; Shigenaga M; Imai M; Nukadzuka Y; Ishimaru Y; Saito K; Yokoyama R; Nishitani K; Ueda M
Bioorg Med Chem Lett; 2016 Jun; 26(12):2974. PubMed ID: 27161279
[No Abstract] [Full Text] [Related]
60. Commentary to "The structure of McN-5652" [Bioorg. Med. Chem. 9 (2001) 2105] and to the corrigendum to "The structure of McN-5652" [Bioorg. Med. Chem. 10 (2002) 3368].
Maryanoff BE
Bioorg Med Chem; 2002 Oct; 10(10):3367. PubMed ID: 12150884
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
